Literature DB >> 14612955

Apoptotic-resistance of the human osteosarcoma cell line HS-Os-1 to irradiation is converted to apoptotic-susceptibility by hydrogen peroxide: a potent role of hydrogen peroxide as a new radiosensitizer.

Yasuhiro Ogawa1, Toshiaki Takahashi, Toshihiro Kobayashi, Shinji Kariya, Akihito Nishioka, Takenao Ohnishi, Toshiji Saibara, Shinji Hamasato, Toshikazu Tani, Harumichi Seguchi, Shoji Yoshida, Hiroshi Sonobe.   

Abstract

In our previous study, we demonstrated that the radioresistance of the human osteosarcoma cell line HS-Os-1, was considered to arise, at least in part, from the low level of ROS formation following irradiation, which in turn may have resulted from the strong scavenging ability of the cells for free radicals, including hydroxyl radicals. Following the study, we found that addition of 1 or 10 mM hydrogen peroxide induced ROS formation, oxidative DNA damage, dysfunction of the mitochondrial membrane potential, and early apoptotic changes in the human osteosarcoma cell line HS-Os-1. We therefore speculated that combined use of irradiation and hydrogen peroxide might exert an additive effect for apoptotic-resistant tumors such as the human osteosarcoma cell line HS-Os-1, in terms of preservation of the radiation-induced hydroxyl radical production supported by the intracellular ROS formation that is induced by exogenous hydrogen peroxide addition. Therefore, in this study, we examined the effect of various doses of irradiation on the existence of 0.1 mM hydrogen peroxide in the culture medium. We found that irradiation with 10 or 20 Gy, under the condition of the presence of 0.1 mM hydrogen peroxide, induced ROS formation, oxidative DNA damage, dysfunction of the mitochondrial membrane potential, and early apoptotic changes in the human osteosarcoma cell line HS-Os-1, though ROS formation and oxidative DNA damage were scarcely seen in response to irradiation of up to 30 Gy, as was shown in our previous study. We therefore concluded that the combined modality of irradiation and such a low concentration of hydrogen peroxide (0.1 mM) is potentially applicable in clinical radiotherapy for many kinds of apoptotic-resistant neoplasms in terms of achieving both local control and improving survival benefit of patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612955

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  11 in total

1.  Development of a novel enzyme-targeting radiosensitizer (KORTUC) containing hydrogen peroxide for intratumoral injection for patients with low linear energy transfer-radioresistant neoplasms.

Authors:  Shiho Tokuhiro; Yasuhiro Ogawa; Kazuhiro Tsuzuki; Ryo Akima; Hironobu Ue; Shinji Kariya; Akihito Nishioka
Journal:  Oncol Lett       Date:  2010-09-23       Impact factor: 2.967

2.  Non-surgical therapy and radiologic assessment of stage I breast cancer treatment with novel enzyme-targeting radiosensitization: Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, type II (KORTUC II).

Authors:  Jiro Hitomi; Kei Kubota; Yasuhiro Ogawa; Norihiko Hamada; Yoriko Murata; Akihito Nishioka
Journal:  Exp Ther Med       Date:  2010-07-20       Impact factor: 2.447

3.  Safety and efficacy of image-guided enzyme-targeting radiosensitization and intraoperative radiotherapy for locally advanced unresectable pancreatic cancer.

Authors:  Akihito Nishioka; Yasuhiro Ogawa; Kana Miyatake; Michiko Tadokoro; Munenobu Nogami; Norihiko Hamada; Kei Kubota; Shinnji Kariya; Takuhiro Kohsaki; Toshiji Saibara; Takehiro Okabayashi; Kazuhiro Hanazaki
Journal:  Oncol Lett       Date:  2014-04-28       Impact factor: 2.967

Review 4.  Paradigm Shift in Radiation Biology/Radiation Oncology-Exploitation of the "H₂O₂ Effect" for Radiotherapy Using Low-LET (Linear Energy Transfer) Radiation such as X-rays and High-Energy Electrons.

Authors:  Yasuhiro Ogawa
Journal:  Cancers (Basel)       Date:  2016-02-25       Impact factor: 6.639

5.  Development of a Novel Enzyme-Targeting Radiosensitizer (New KORTUC) Using a Gelatin-Based Hydrogel Instead of a Sodium Hyaluronate.

Authors:  Shiho Morita-Tokuhiro; Yasuhiro Ogawa; Norikazu Yokota; Akira Tsuzuki; Hideki Oda; Naoya Ishida; Nobutaka Aoyama; Akihito Nishioka
Journal:  Cancers (Basel)       Date:  2016-01-07       Impact factor: 6.639

6.  High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report.

Authors:  Mio Nakata; Ken Yoshida; Taiju Shimbo; Nobuhiko Yoshikawa; Hiroto Yoshioka; Akihiro Hori; Chikara Sato; Yasuo Uesugi; Yuhei Kogata; Koji Masui; Naoya Murakami; Tairo Kashihara; Hironori Akiyama; Nikolaos Tselis; Masahide Ohmichi; Keiji Nihei
Journal:  J Contemp Brachytherapy       Date:  2020-12-16

7.  Evaluation of Changes in Tumor Shadows and Microcalcifications on Mammography Following KORTUC II, a New Radiosensitization Treatment without any Surgical Procedure for Elderly Patients with Stage I and II Breast Cancer.

Authors:  Akira Tsuzuki; Yasuhiro Ogawa; Kei Kubota; Shiho Tokuhiro; Ryo Akima; Shin Yaogawa; Kenji Itoh; Yoko Yamada; Toshikazu Sasaki; Masahide Onogawa; Tomoaki Yamanishi; Shinji Kariya; Munenobu Nogami; Akihito Nishioka; Mitsuhiko Miyamura
Journal:  Cancers (Basel)       Date:  2011-09-09       Impact factor: 6.639

8.  Computed Tomography Demonstration of the Production and Distribution of Oxygen Gas Following Intratumoral Injection of a New Radiosensitizer (KORTUC) for Patients with Breast Cancer-Is Intratumoral Injection Not an Ideal Approach to Solve the Major Problem of Tumor Hypoxia in Radiotherapy?

Authors:  Naoya Hayashi; Yasuhiro Ogawa; Kei Kubota; Kazuhiro Okino; Ryo Akima; Shiho Morita-Tokuhiro; Akira Tsuzuki; Shin Yaogawa; Akihito Nishioka; Mitsuhiko Miyamura
Journal:  Cancers (Basel)       Date:  2016-04-01       Impact factor: 6.639

9.  Non-Surgical Breast-Conserving Treatment (KORTUC-BCT) Using a New Radiosensitization Method (KORTUC II) for Patients with Stage I or II Breast Cancer.

Authors:  Yasuhiro Ogawa; Kei Kubota; Nobutaka Aoyama; Tomoaki Yamanishi; Shinji Kariya; Norihiko Hamada; Munenobu Nogami; Akihito Nishioka; Masahide Onogawa; Mitsuhiko Miyamura
Journal:  Cancers (Basel)       Date:  2015-11-17       Impact factor: 6.639

10.  Serial Assessment of Therapeutic Response to a New Radiosensitization Treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), in Patients with Stage I/II Breast Cancer Using Breast Contrast-Enhanced Magnetic Resonance Imaging.

Authors:  Shin Yaogawa; Yasuhiro Ogawa; Shiho Morita-Tokuhiro; Akira Tsuzuki; Ryo Akima; Kenji Itoh; Kazuo Morio; Hiroaki Yasunami; Masahide Onogawa; Shinji Kariya; Munenobu Nogami; Akihito Nishioka; Mitsuhiko Miyamura
Journal:  Cancers (Basel)       Date:  2015-12-22       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.